Concepedia

Daria Timonina

DT

Statistics

Publications

11

Citations

1.4K

H-Index

11

Active since

2016

Affiliations

Massachusetts General Hospital(Current)

Harvard University

Broad Institute

Lomonosov Moscow State University

University of California, Irvine

Daria Timonina is an author at Massachusetts General Hospital specializing in medicine, cell biology, and tumor biology.

Top concepts

Publications per year

2016–2023

11

Publications

11

Sequential ALK Inhibitors Can Select for Lorlatinib-Resistant Compound <i>ALK</i> Mutations in ALK-Positive Lung Cancer

Satoshi Yoda, Michael S. Lawrence, Benjamin J. Burke et al. · Cancer Discovery · 2018 · 298 citations · Full text

KRAS G12C NSCLC Models Are Sensitive to Direct Targeting of KRAS in Combination with PI3K Inhibition

Sandra Misale, Jackson P. Fatherree, Eliane Cortez et al. · Clinical Cancer Research · 2018 · 253 citations

PTEN Loss Mediates Clinical Cross-Resistance to CDK4/6 and PI3Kα Inhibitors in Breast Cancer

Carlotta Costa, Ye Wang, Amy Ly et al. · Cancer Discovery · 2019 · 245 citations · Full text

Targeting FGFR overcomes EMT-mediated resistance in EGFR mutant non-small cell lung cancer

Sana Raoof, Iain J. Mulford, Heidie Frisco Cabanos et al. · Oncogene · 2019 · 207 citations · Full text

, , +8

Therapy-induced APOBEC3A drives evolution of persistent cancer cells

Hideko Isozaki, Ramin Sakhtemani, Ammal Abbasi et al. · Nature · 2023 · 130 citations · Full text

, , +4

1–5 of 11